Google and pharmaceutical giants Novartis are teaming up to develop Google Lens, a smart contact lens that could have a wide array of medical applications. The technology-packed lenses could help people suffering from visibility problems and other illnesses.
The lenses will be fitted with a glucose sensor as well as a chip and antenna that receive power and transmit information.
The lenses could be embedded with technology capable of analyzing lacryglobin, a chemical found in tears that acts as a biological marker for several different kinds of cancers.
The Google Lens could even be used to assist drug delivery into the wearer's system. It could be designed to dispense medication over a period of time, which could be more effective than providing short, concentrated doses as is the case with regular eye drops.
What's Driving This Trend
- Smart Contact Lens
- Developing smart contact lenses to help people with visual problems and illnesses presents disruptive innovation opportunities for healthcare.
- Glucose Sensing Technology
- Incorporating glucose sensing technologies into smart contact lenses opens up new possibilities for diabetes and glucose level management.
- Biological Marker Detection
- Smart contact lenses with the ability to detect biological markers in tears such as lacryglobin could revolutionize early detection of diseases, including cancer.
Who This Affects Most
- Healthcare
- Smart contact lenses have the potential to disrupt the traditional healthcare industry by providing more personalized and convenient treatment options.
- Pharmaceuticals
- Developing smart contact lenses with medication delivery capabilities presents opportunities for innovation and competition in the pharmaceutical industry.
- Ophthalmology
- The development of smart contact lenses could disrupt traditional ophthalmology practices, enabling new forms of treatment, early detection, and diagnosis of diseases.
